Caliskan H, Onal D, Nalcaci E
BMC Immunol. 2024; 25(1):75.
PMID: 39523336
PMC: 11552158.
DOI: 10.1186/s12865-024-00665-5.
Miskowiak K, Damgaard V, Schandorff J, Macoveanu J, Knudsen G, Johansen A
Trials. 2024; 25(1):648.
PMID: 39363230
PMC: 11447976.
DOI: 10.1186/s13063-024-08463-5.
Kalluru P, Bhavanthi S, Vashist S, Gopavaram R, Mamilla M, Sharma S
Ann Med Surg (Lond). 2024; 86(6):3608-3614.
PMID: 38846819
PMC: 11152865.
DOI: 10.1097/MS9.0000000000002113.
Rothschadl M, Sathyanesan M, Newton S
Life (Basel). 2023; 13(9).
PMID: 37763230
PMC: 10532867.
DOI: 10.3390/life13091826.
Singh M, Zhao Y, Daguano Gastaldi V, Wojcik S, Curto Y, Kawaguchi R
Nat Commun. 2023; 14(1):4777.
PMID: 37604818
PMC: 10442354.
DOI: 10.1038/s41467-023-40332-8.
The cytokine receptor CRLF3 is a human neuroprotective EV-3 (Epo) receptor.
Knorr D, Rodriguez Polo I, Pies H, Schwedhelm-Domeyer N, Pauls S, Behr R
Front Mol Neurosci. 2023; 16:1154509.
PMID: 37168680
PMC: 10165946.
DOI: 10.3389/fnmol.2023.1154509.
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research.
Colwell M, Tagomori H, Chapman S, Gillespie A, Cowen P, Harmer C
Transl Psychiatry. 2022; 12(1):484.
PMID: 36396622
PMC: 9671959.
DOI: 10.1038/s41398-022-02249-6.
Antidepressant-like effects of trophic factor receptor signaling.
Sathyanesan M, Newton S
Front Mol Neurosci. 2022; 15:958797.
PMID: 36081576
PMC: 9445421.
DOI: 10.3389/fnmol.2022.958797.
Association of Endogenous Erythropoietin Levels and Iron Status With Cognitive Functioning in the General Population.
Ayerdem G, Bosma M, Vinke J, Ziengs A, Potgieser A, Gansevoort R
Front Aging Neurosci. 2022; 14:862856.
PMID: 35462689
PMC: 9024369.
DOI: 10.3389/fnagi.2022.862856.
Introducing the brain erythropoietin circle to explain adaptive brain hardware upgrade and improved performance.
Ehrenreich H, Garcia-Agudo L, Steixner-Kumar A, Wilke J, Butt U
Mol Psychiatry. 2022; 27(5):2372-2379.
PMID: 35414656
PMC: 9004453.
DOI: 10.1038/s41380-022-01551-5.
Erythropoietin and Non-Erythropoietic Derivatives in Cognition.
Newton S, Sathyanesan M
Front Pharmacol. 2021; 12:728725.
PMID: 34552490
PMC: 8450392.
DOI: 10.3389/fphar.2021.728725.
Erythropoietin promotes hippocampal mitochondrial function and enhances cognition in mice.
Jacobs R, Aboouf M, Koester-Hegmann C, Muttathukunnel P, Laouafa S, Arias-Reyes C
Commun Biol. 2021; 4(1):938.
PMID: 34354241
PMC: 8342552.
DOI: 10.1038/s42003-021-02465-8.
Lack of association between erythropoietin treatment and risk of depression in patients with end-stage kidney disease on maintenance dialysis: a nationwide database study in Taiwan.
Lin P, Li L, Wang L, Yang Y, Hsu C
Ther Adv Chronic Dis. 2021; 12:2040622321995690.
PMID: 33747426
PMC: 7940772.
DOI: 10.1177/2040622321995690.
Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin.
Wakhloo D, Scharkowski F, Curto Y, Butt U, Bansal V, Steixner-Kumar A
Nat Commun. 2020; 11(1):1313.
PMID: 32152318
PMC: 7062779.
DOI: 10.1038/s41467-020-15041-1.
Delaying memory decline: different options and emerging solutions.
Schneider F, Horowitz A, Lesch K, Dandekar T
Transl Psychiatry. 2020; 10(1):13.
PMID: 32066684
PMC: 7026464.
DOI: 10.1038/s41398-020-0697-x.
Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial.
Petersen J, Schmidt L, Vinberg M, Jorgensen M, Hageman I, Ehrenreich H
Trials. 2018; 19(1):611.
PMID: 30400939
PMC: 6220567.
DOI: 10.1186/s13063-018-2995-7.
GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?.
Inkster B, Zai G, Lewis G, Miskowiak K
Transl Psychiatry. 2018; 8(1):216.
PMID: 30310078
PMC: 6181907.
DOI: 10.1038/s41398-018-0270-z.
Extended Erythropoietin Treatment Prevents Chronic Executive Functional and Microstructural Deficits Following Early Severe Traumatic Brain Injury in Rats.
Robinson S, Winer J, Chan L, Oppong A, Yellowhair T, Maxwell J
Front Neurol. 2018; 9:451.
PMID: 29971038
PMC: 6018393.
DOI: 10.3389/fneur.2018.00451.
Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
Schmidt L, Petersen J, Vinberg M, Hageman I, Olsen N, Kessing L
Trials. 2018; 19(1):234.
PMID: 29673379
PMC: 5909268.
DOI: 10.1186/s13063-018-2627-2.
Alternative Erythropoietin Receptors in the Nervous System.
Ostrowski D, Heinrich R
J Clin Med. 2018; 7(2).
PMID: 29393890
PMC: 5852440.
DOI: 10.3390/jcm7020024.